Why valganciclovir should not be indicated for liver recipients and high-dose acyclovir should not be removed from international cytomegalovirus guidelines

Research output: Contribution to journalLetter

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)e8-e9
JournalTransplantation
Volume91
Issue number1
DOIs
StatePublished - Jan 15 2011

ASJC Scopus subject areas

  • Transplantation

Cite this